Although a positive correlation between circulating concentrations of PCSK9 and major adverse cardiovascular (CV) events in patients with stable CHD have indicated by several lines of evidence, the potential of PCSK9 in the prediction of major adverse cardiovascular events in patients with AMI in particularly based on sex differences is requires further prospective investigation. This evidence concerns the gene PCSK9 and coronary artery disorder.